Rangering i aksjer
#35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Aksjekurs
$0.05994921
Sist synkronisert: 2026-08-13
Handel Tissue Repair Ltd (TRP)
Pris TRP pris med markedsverdi på B
Markedsverdi av Tissue Repair Ltd(TRP)
Markedsverdi: $3.62M
Per August 2026 har Tissue Repair Ltd en markedsverdi på $3.62M. Dette gjør Tissue Repair Ltd til det 35634th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Tissue Repair Ltd fra 2021 til 2026
TRP sammenlignet med topp 5 mest populære stocks
| Pris på TRP |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+150,398,076.29%
|
|
|
|
|
$4.490T
|
+123,864,028.40%
|
|
|
|
|
$4.162T
|
+114,826,314.58%
|
|
|
|
|
$3.676T
|
+101,417,473.82%
|
|
|
|
|
$2.833T
|
+78,153,748.39%
|
